66. IgA腎症 IgA nephropathy Clinical trials / Disease details

臨床試験数 : 255 / 薬物数 : 255 - (DrugBank : 79) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 137

16 trials found

diseases per page:

Showing 1 to 10 of 16 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2018-000075-33-GR (EUCTR)	13/10/2021	13/07/2021	OMS721 in patients with IgA Nephropathy (ARTEMIS-IGAN)	A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Safety and Efficacy of OMS721in ...	IgA nephropathy (IgAN) MedDRA version: 20.1;Level: PT;Classification code 10029151;Term: Nephropathy ...	Product Code: OMS721 INN or Proposed INN: OMS721 Other descriptive name: OMS721	Omeros Corporation	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	450	Phase 3	United States;Taiwan;Slovakia;Greece;Thailand;Spain;Italy;Australia;China;Korea, Republic of;Czechia ...
2	EUCTR2018-000075-33-DE (EUCTR)	19/12/2019	01/07/2019	OMS721 in patients with IgA Nephropathy (ARTEMIS-IGAN)	A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Safety and Efficacy of OMS721in ...	IgA nephropathy (IgAN);Therapeutic area: Diseases [C] - Immune System Diseases [C20]	Product Name: Narsoplimab Product Code: OMS721 INN or Proposed INN: Narsoplimab Other descriptive name: ...	Omeros Corporation	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	450	Phase 3	United States;Taiwan;Slovakia;Spain;Thailand;Lithuania;Austria;Italy;United Kingdom;Hungary;Czech Re ...
3	EUCTR2018-000075-33-GB (EUCTR)	06/11/2019	27/06/2019	OMS721 in patients with IgA Nephropathy (ARTEMIS-IGAN)	A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Safety and Efficacy of OMS721in ...	IgA nephropathy (IgAN);Therapeutic area: Diseases [C] - Immune System Diseases [C20]	Product Code: OMS721 INN or Proposed INN: OMS721 Other descriptive name: OMS721	Omeros Corporation	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	450	Phase 3	United States;Philippines;Taiwan;Slovakia;Spain;Thailand;Lithuania;Austria;United Kingdom;Hungary;Cz ...
4	EUCTR2018-000075-33-IT (EUCTR)	26/09/2019	18/06/2021	OMS721 in patients with IgA Nephropathy (ARTEMIS-IGAN)	A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Safety and Efficacy of OMS721in ...	IgA nephropathy (IgAN) MedDRA version: 20.0;Level: SOC;Classification code 10038359;Term: Renal and ...	Product Name: OMS721 Product Code: [OMS721] INN or Proposed INN: OMS721	OMEROS CORPORATION	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	450	Phase 3	United States;Philippines;Taiwan;Slovakia;Spain;Korea, Democratic People's Republic of;Lithuania;Aus ...
5	EUCTR2018-000075-33-AT (EUCTR)	15/11/2018	25/06/2018	OMS721 in patients with IgA Nephropathy (ARTEMIS-IGAN)	A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Safety and Efficacy of OMS721in ...	IgA nephropathy (IgAN) MedDRA version: 20.1;Level: PT;Classification code 10029151;Term: Nephropathy ...	Product Code: OMS721 INN or Proposed INN: OMS721 Other descriptive name: OMS721	Omeros Corporation	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	450	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United States;Philippines;Taiwan;Slovakia;Spain;Lithuania;Austria;Hungary;Czech Republic;Canada;Pola ...
6	EUCTR2018-000075-33-BE (EUCTR)	03/10/2018	31/05/2018	OMS721 in patients with IgA Nephropathy (ARTEMIS-IGAN)	A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Safety and Efficacy of OMS721in ...	IgA nephropathy (IgAN) MedDRA version: 20.1;Level: PT;Classification code 10029151;Term: Nephropathy ...	Product Name: Narsoplimab Product Code: OMS721 INN or Proposed INN: Narsoplimab Other descriptive name: ...	Omeros Corporation	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	450	Phase 3	United States;Taiwan;Slovakia;Spain;Thailand;Lithuania;Austria;United Kingdom;Hungary;Czech Republic ...
7	EUCTR2018-000075-33-PL (EUCTR)	17/09/2018	10/07/2018	OMS721 in patients with IgA Nephropathy (ARTEMIS-IGAN)	A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Safety and Efficacy of OMS721in ...	IgA nephropathy (IgAN) MedDRA version: 20.1;Level: PT;Classification code 10029151;Term: Nephropathy ...	Product Code: OMS721 INN or Proposed INN: OMS721 Other descriptive name: OMS721	Omeros Corporation	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	450	Phase 3	United States;Taiwan;Slovakia;Spain;Thailand;Lithuania;Austria;United Kingdom;Hungary;Czech Republic ...
8	EUCTR2018-000075-33-CZ (EUCTR)	06/09/2018	06/04/2018	OMS721 in patients with IgA Nephropathy (ARTEMIS-IGAN)	A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Safety and Efficacy of OMS721in ...	IgA nephropathy (IgAN) MedDRA version: 20.1;Level: PT;Classification code 10029151;Term: Nephropathy ...	Product Code: OMS721 INN or Proposed INN: OMS721 Other descriptive name: OMS721	Omeros Corporation	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	450	Phase 3	United States;Philippines;Taiwan;Slovakia;Spain;Thailand;Lithuania;Austria;United Kingdom;Czech Repu ...
9	EUCTR2018-000075-33-BG (EUCTR)	05/09/2018	19/07/2018	OMS721 in patients with IgA Nephropathy (ARTEMIS-IGAN)	A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Safety and Efficacy of OMS721in ...	IgA nephropathy (IgAN) MedDRA version: 20.1;Level: PT;Classification code 10029151;Term: Nephropathy ...	Product Name: Narsoplimab Product Code: OMS721 INN or Proposed INN: Narsoplimab Other descriptive name: ...	Omeros Corporation	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	450	Phase 3	United States;Taiwan;Slovakia;Spain;Thailand;Lithuania;Austria;United Kingdom;Hungary;Czech Republic ...
10	EUCTR2018-000075-33-SE (EUCTR)	03/09/2018	03/05/2018	OMS721 in patients with IgA Nephropathy (ARTEMIS-IGAN)	A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Safety and Efficacy of OMS721in ...	IgA nephropathy (IgAN) MedDRA version: 20.1;Level: PT;Classification code 10029151;Term: Nephropathy ...	Product Name: Narsoplimab Product Code: OMS721 INN or Proposed INN: Narsoplimab Other descriptive name: ...	Omeros Corporation	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	450	Phase 3	United States;Taiwan;Slovakia;Spain;Thailand;Lithuania;Austria;United Kingdom;Hungary;Czech Republic ...

First Previous1 2Next Last